Ngapas, Acmad N.
HRN: 28-10-22 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/06/2025
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
12/06/2025
12/12/2025
IVTT
2.25 G
Q6
Cap HR
Checking Final Appropriateness
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes